Originally intended dual and triple-combination formulations for jet nebulizers could be successfully delivered with three mesh nebulizer among which Pulmogine presented better performance.
Mesh nebulisers in conjunction with innovative treatments are creating a new era of drug-device combination products that aim to target all types of respiratory diseases
Deepro was found not to exhibit substantial mesh clogging during two challenge tests, considering the expected effects of clogging. The performance of the device was described as stable even when it was not washed for up to 5 days.
